BEAM
Beam Therapeutics Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +18.2% ·
share flow +10.8% ·
net new positions +15.4%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 98 | +9 | 71.47M | $2.45B | +12 | −3 |
| Q1 2026 | 92 | +3 | 70.17M | $1.67B | +9 | −6 |
| Q4 2025 | 89 | +3 | 73.41M | $2.04B | +4 | −1 |
| Q3 2025 | 16 | -1 | 52.77M | $1.28B | +1 | −2 |
| Q2 2025 | 14 | 0 | 51.27M | $872.17M | +1 | −1 |
| Q1 2025 | 11 | -2 | 20.67M | $403.69M | — | −2 |
| Q4 2024 | 13 | +2 | 16.59M | $411.47M | +3 | −1 |
| Q3 2024 | 10 | -1 | 11.89M | $291.41M | — | −1 |
| Q2 2024 | 11 | — | 12.82M | $300.27M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 7.07M | +8.2% | $175.29M | 1.5% | ▲ Add | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passive) | 3.08M | — | $76.32M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 2.06M | +37.8% | $51.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 2.06M | +37.8% | $51.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.80M | -0.2% | $44.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 1.80M | -0.2% | $44.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 1.75M | +17.9% | $43.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 1.75M | +17.9% | $43.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Baillie Gifford ✦ | 308.24K | -13.8% | $7.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Baillie Gifford ✦ | 308.24K | -13.8% | $7.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Baillie Gifford ✦ | 308.24K | -13.8% | $7.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 193.36K | New | $4.80M | 0.0% | New | 1 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 117.09K | +75.2% | $2.90M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Millennium Management ✦ | 75.35K | -7.8% | $1.87M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Marshall Wace ✦ | 55.00K | New | $1.36M | 0.0% | New | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 55.00K | New | $1.36M | 0.0% | New | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 35.57K | -8.8% | $882,111 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 35.57K | -8.8% | $882,111 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Wellington Management ✦ | 35.57K | -8.8% | $882,111 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 35.57K | -8.8% | $882,111 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Renaissance Technologies ✦ | 22.91K | New | $568,094 | 0.0% | New | 1 | SEC ↗ |
| 22 | Norges Bank ✦ (passive) | 18.59K | 0.0% | $461,057 | 0.0% | Held | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $4.80M | 0.0% |
| Marshall Wace | $1.36M | 0.0% |
| Marshall Wace | $1.36M | 0.0% |
| Renaissance Technologies | $568,094 | 0.0% |
Exited
| AQR Capital Management | $216,629 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 248 holders, 107.79M shares, $2.49B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.